Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†
Open Access
- 18 August 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 20 (23) , 4693-4706
Abstract
A genome-wide association study (GWAS) identified single-nucleotide polymorphisms (SNPs) at 1p11.2 and 14q24.1 (RAD51L1) as breast cancer susceptibility loci. The initial GWAS suggested stronger effects for both loci for estrogen receptor (ER)-positive tumors. Using data from the Breast Cancer Association Consortium (BCAC), we sought to determine whether risks differ by ER, progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), grade, node status, tumor size, and ductal or lobular morphology. We genotyped rs11249433 at 1p.11.2, and two highly correlated SNPs rs999737 and rs10483813 (r2= 0.98) at 14q24.1 (RAD51L1), for up to 46 036 invasive breast cancer cases and 46 930 controls from 39 studies. Analyses by tumor characteristics focused on subjects reporting to be white women of European ancestry and were based on 25 458 cases, of which 87% had ER data. The SNP at 1p11.2 showed significantly stronger associations with ER-positive tumors [per-allele odds ratio (OR) for ER-positive tumors was 1.13, 95% CI = 1.10–1.16 and, for ER-negative tumors, OR was 1.03, 95% CI = 0.98–1.07, case-only P-heterogeneity = 7.6 × 10−5]. The association with ER-positive tumors was stronger for tumors of lower grade (case-only P= 6.7 × 10−3) and lobular histology (case-only P= 0.01). SNPs at 14q24.1 were associated with risk for most tumor subtypes evaluated, including triple-negative breast cancers, which has not been described previously. Our results underscore the need for large pooling efforts with tumor pathology data to help refine risk estimates for SNP associations with susceptibility to different subtypes of breast cancer.Keywords
This publication has 27 references indexed in Scilit:
- Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersHuman Molecular Genetics, 2011
- Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative AnalysisJNCI: Journal of the National Cancer Institute, 2008
- Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studiesThe American Journal of Clinical Nutrition, 2008
- Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association ConsortiumCancer Research, 2007
- Diabetes, metabolic syndrome, and breast cancer: a review of the current evidenceThe American Journal of Clinical Nutrition, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancerNature Genetics, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- A common coding variant in CASP8 is associated with breast cancer riskNature Genetics, 2007
- Complex Formation by the Human Rad51B and Rad51C DNA Repair Proteins and Their Activities in VitroJournal of Biological Chemistry, 2003